FILOPANTI, MARCELLO
FILOPANTI, MARCELLO
DIPARTIMENTO DI SCIENZE MEDICHE (attivo dal 01/01/2000 al 27/04/2012)
Analysis of genetic variants of phosphodiesterase 11A (PDE11A) in acromegalic patients
2009 E. Peverelli, F. Ermetici, M. Filopanti, F. Elli, C. Ronchi, G. Mantovani, S. Ferrero, S. Bosari, P. Beck-Peccoz, A. Lania, A. Spada
Analysis of somatostatin receptors 2 and 5 polymorphisms in patients with acromegaly
2005 M. Filopanti, C. Ronchi, E. Ballare, S. Bondioni, A.G. Lania, M. Losa, S. Gelmini, A. Peri, C. Orlando, P. Beck-Peccoz, A. Spada
Biallelic expression of the Gsalpha gene in human bone and adipose tissue
2004 G. Mantovani, S. Bondioni, M. Locatelli, C. Pedroni, A.G. Lania, E. Ferrante, M. Filopanti, P. Beck-Peccoz, A. Spada
Bone quality, as measured by trabecular bone score, in patients with primary hyperparathyroidism
2013 C. Eller-Vainicher, M. Filopanti, S. Palmieri, F.M. Ulivieri, V. Morelli, V.V. Zhukouskaya, E. Cairoli, R. Pino, A. Naccarato, U. Verga, A. Scillitani, P. Beck-Peccoz, I. Chiodini
Diagnostic features and outcome of surgical therapy of acromegalic patients : experience of the last three decades
2014 E. Sala, E. Ferrante, M. Locatelli, P. Rampini, G. Mantovani, C. Giavoli, M. Filopanti, E. Verrua, E. Malchiodi, G. Carrabba, M. Arosio, P. Beck-Peccoz, A. Spada, A.G. Lania
Dopamine D2 receptor gene polymorphisms and response to cabergoline therapy in patients with prolactin-secreting pituitary adenomas
2008 M. Filopanti, A.M. Barbieri, A.R. Angioni, A. Colao, V. Gasco, S. Grottoli, A. Peri, S. Baglioni, M.F. Fustini, F. Pigliaru, P.D. Monte, G. Borretta, B. Ambrosi, M.L. Jaffrain Rea, M. Gasperi, S. Brogioni, S. Cannavò, G. Mantovani, P. Beck Peccoz, A. Lania, A. Spada
Double pituitary and conserved function in an adult patient with neurofibromatosis type 1
2011 M. Filopanti, U. Verga, F. Ermetici, F. Natacci, F. Lalatta, S. Avignone, L. Trespidi, P. Beck Peccoz, G. Mantovani, A.G. Lania, A. Spada
Estimated glomerular filtration rate by serum cystatin C correlates with cardiometabolic parameters in patients with primary hyperparathyroidism
2015 F. Ermetici, M. Filopanti, U. Verga, E. Passeri, G. Dito, A.E. Malavazos, C. Mapelli, M.E. Raggi, A. Spada, S. Corbetta
GH response to oral glucose tolerance test : a comparison between patients with acromegaly and other pituitary disorders
2011 E. Verrua, M. Filopanti, C.L. Ronchi, L. Olgiati, E. Ferrante, C. Giavoli, E. Sala, G. Mantovani, M. Arosio, P. Beck Peccoz, A.G. Lania, A. Spada
Growth hormone receptor variants and response to pegvisomant in monotherapy or in combination with somatostatin analogs in acromegalic patients : a multicenter study
2012 M. Filopanti, L. Olgiati, G. Mantovani, S. Corbetta, M. Arosio, V. Gasco, L. De Marinis, C. Martini, F. Bogazzi, S. Cannavò, A. Colao, D. Ferone, G. Arnaldi, F. Pigliaru, A. Peri, G. Angeletti, M.L. Jaffrain Rea, A.G. Lania, A. Spada
Growth hormone-releasing hormone-producing pancreatic neuroendocrine tumor in a multiple endocrine neoplasia type 1 family with an uncommon phenotype
2013 E. Sala, E. Ferrante, E. Verrua, E. Malchiodi, G. Mantovani, M. Filopanti, S. Ferrero, A. Pietrabissa, A. Vanoli, S. La Rosa, M. Zatelli, P. Beck-Peccoz, U. Verga
Hypothalamic-Pituitary Axis in Non-Functioning Pituitary Adenomas : focus on the Prevalence of Isolated Central Hypoadrenalism
2015 G. Carosi, E. Malchiodi, E. Ferrante, E. Sala, E. Verrua, E. Profka, C. Giavoli, M. Filopanti, P. Beck-Peccoz, A. Spada, G. Mantovani
Impact of IGF(CA)19 gene polymorphism on the metabolic response to GH therapy in adult GH-deficient patients
2014 C. Giavoli, E. Profka, E. Sala, M. Filopanti, A.M. Barbieri, S. Bergamaschi, E. Ferrante, M. Arosio, B. Ambrosi, A.G. Lania, A. Spada, P. Beck-Peccoz
Loss of heterozygosity at the SS receptor type 5 locus in human GH- and TSH-secreting pituitary adenomas
2004 M. Filopanti, E. Ballare, A.G. Lania, S. Bondioni, U. Verga, M. Locatelli, L.M. Zavanone, M. Losa, S. Gelmini, A. Peri, C. Orlando, P. Beck-Peccoz, A. Spada
MEN1-related hyperparathyroidism : response to cinacalcet and its relationship with the calcium-sensing receptor gene variant Arg990Gly
2012 M. Filopanti, U. Verga, F. Ermetici, L. Olgiati, C. Eller-Vainicher, S. Corbetta, L. Persani, P. Beck Peccoz, A. Spada
Mutation of somatostatin receptor type 5 in an acromegalic patient resistant to somatostatin analog treatment
2001 E. Ballare', L. Persani, A.G. Lania, M. Filopanti, E. Giammona, S. Corbetta, S. Mantovani, M. Arosio, P. Beck-Peccoz, G. Faglia, A. Spada
Pharmacology of the calcium sensing receptor
2013 M. Filopanti, S. Corbetta, A.M. Barbieri, A. Spada
Quantitative analysis of methylation defects and correlation with clinical characteristics in patients with pseudohypoparathyroidism type I and GNAS epigenetic alterations
2014 F.M. Elli, L. De Sanctis, V. Bollati, L. Tarantini, M. Filopanti, A.M. Barbieri, E. Peverelli, P. Beck-Peccoz, A. Spada, G. Mantovani
R990G polymorphism of the calcium-sensing receptor and renal calcium excretion in patients with primary hyperparathyroidism
2006 S. Corbetta, C. Eller-Vainicher, M. Filopanti, P. Saeli, G. Vezzoli, T. Arcidiacono, P. Loli, M.L. Syren, L. Soldati, P. Beck-Peccoz, A. Spada
Recurrence of hyperprolactinemia following dopamine agonist withdrawal and possible predictive factors of recurrence in prolactinomas
2016 E. Sala, P. Bellaviti Buttoni, E. Malchiodi, E. Verrua, G. Carosi, E. Profka, G. Rodari, M. Filopanti, E. Ferrante, A. Spada, G. Mantovani